CAR-T Hepatic Artery Infusions and Sir-Spheres for Liver Metastases

Phase 1 Completed 8 enrolled Roger Williams Medical Center Sirtex Medical · collab

NaSingle-groupOpen-labelTreatment

Summary

This is an open label fixed dose phase Ib of anti-CEA CAR-T cells hepatic artery infusions and yttrium-90 SIR-Spheres in patients with CEA-expressing liver metastases.

Timeline

Start: 2015-04
Primary completion: 2016-11-21
Completion: 2018-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	anti-CEA CAR-T cells	Cell therapy	—	Other

Indications

No indication recorded.